# Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

> **NCT01498653** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 313 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW685698/GW642444
- **DRUG:** CCI18781

## Key facts

- **NCT ID:** NCT01498653
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498653, "Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01498653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*